Oric Pharmaceuticals Inc.(ORIC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ORIC Oric Pharmaceuticals Inc.

交易中 02-10 12:51:06 EST

10.93

+0.22

+2.05%

最高11.08	最低10.53	成交量33.45万
今开10.72	昨收10.71	日振幅5.14%
总市值10.64亿	流通市值6.63亿	总股本9,739万
成交额363.01万	换手率0.55%	流通股本6,066万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ORIC","market":"US","secType":"STK","nameCN":"Oric Pharmaceuticals Inc.","latestPrice":10.93,"timestamp":1770745864087,"preClose":10.71,"halted":0,"volume":334546,"delay":0,"changeRate":0.02054154995331455,"floatShares":60659100,"shares":97389279,"eps":-1.69572,"marketStatus":"交易中","change":0.22,"latestTime":"02-10 12:51:06 EST","open":10.72,"high":11.08,"low":10.53,"amount":3630055.6058320003,"amplitude":0.051354,"askPrice":10.95,"askSize":338,"bidPrice":10.91,"bidSize":474,"shortable":3,"etf":0,"ttmEps":-1.69572,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1770757200000},"marketStatusCode":2,"adr":0,"listingDate":1587700800000,"exchange":"NASDAQ","adjPreClose":10.71,"preHourTrading":{"tag":"盘前","latestPrice":11.2777,"preClose":10.71,"latestTime":"09:04 EST","volume":212,"amount":2242.704964,"timestamp":1770732245487,"change":0.5677,"changeRate":0.053007,"amplitude":0.22409},"postHourTrading":{"tag":"盘后","latestPrice":10.3168,"preClose":10.71,"latestTime":"17:26 EST","volume":14897,"amount":159397.022,"timestamp":1770676019201,"change":-0.3932,"changeRate":-0.036713,"amplitude":0.036713},"volumeRatio":0.488552,"impliedVol":1.1283,"impliedVolPercentile":0.6853},"requestUrl":"/m/hq/s/ORIC","defaultTab":"news","newsList":[{"id":"2593734104","title":"2026美股生物科技板块怎么投资？杰富瑞：关注这6大首选股、7大潜力标的和5大并购目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2593734104","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593734104?lang=zh_cn&edition=full","pubTime":"2025-12-25 06:00","pubTimestamp":1766613621,"startTime":"0","endTime":"0","summary":"杰富瑞近日发布了关于2026年美股生物科技行业的展望报告，聚焦行业首选投资标的、被低估的潜力企业和潜在并购机会。","market":"sg","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385521.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"2026美股生物科技板块怎么投资？杰富瑞：关注这6大首选股、7大潜力标的和5大并购目标","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["TYRA","TNGX","LENZ","ORIC","SLDB","TSHA"],"gpt_icon":1},{"id":"1117121799","title":"Oric® Pharmaceuticals在2025年ESMO亚洲大会上宣布Enozertinib（Oric-114）关于EGFR非典型和EGFR外显子20非小细胞肺癌的最新口头报告","url":"https://stock-news.laohu8.com/highlight/detail?id=1117121799","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117121799?lang=zh_cn&edition=full","pubTime":"2025-12-04 05:02","pubTimestamp":1764795742,"startTime":"0","endTime":"0","summary":"Oric® Pharmaceuticals在2025年ESMO亚洲大会上宣布Enozertinib（Oric-114）关于EGFR非典型和EGFR外显子20非小细胞肺癌的最新口头报告。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORIC","BK4139"],"gpt_icon":0},{"id":"1128963466","title":"Oric Pharmaceuticals第三季度净收入为-3258.7万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1128963466","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128963466?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:45","pubTimestamp":1763574350,"startTime":"0","endTime":"0","summary":"11月13日 - Oric Pharmaceuticals第三季度运营支出为3667.1万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ORIC"],"gpt_icon":0},{"id":"1189416261","title":"Oric Pharmaceuticals公布根据纳斯达克上市规则5635(C)(4)的诱因授予","url":"https://stock-news.laohu8.com/highlight/detail?id=1189416261","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189416261?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:13","pubTimestamp":1763572428,"startTime":"0","endTime":"0","summary":"Oric Pharmaceuticals Inc. ::*ORIC PHARMACEUTICALS公布根据纳斯达克上市规则5635(C)(4)的诱因授予","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORIC","BK4139"],"gpt_icon":0},{"id":"1187798230","title":"Oric® Pharmaceuticals宣布Oric-944 1B期临床试验剂量探索部分完成，并持续展现潜在的最佳疗效与安全性","url":"https://stock-news.laohu8.com/highlight/detail?id=1187798230","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187798230?lang=zh_cn&edition=full","pubTime":"2025-11-14 05:06","pubTimestamp":1763067973,"startTime":"0","endTime":"0","summary":"Oric® Pharmaceuticals宣布Oric-944 1B期临床试验的剂量探索部分已完成，并继续展现出潜在的最佳疗效与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORIC","BK4139"],"gpt_icon":0},{"id":"2518755942","title":"Oric Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518755942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518755942?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:31","pubTimestamp":1741617117,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时31分，Oric Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.25%。截至发稿，该股报7.58美元/股，成交量7.5166万股，换手率0.11%，振幅3.63%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Aeon Biopharma, Inc.较为活跃，换手率分别为3460.23%、733.65%、526.63%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.，振幅分别为41.36%、40.33%、40.24%。Oric Pharmaceuticals, Inc.公司简介：ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310223157a26a3bd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310223157a26a3bd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2516631766","title":"Oric Pharmaceuticals, Inc.盘中异动 临近收盘快速下跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516631766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516631766?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:41","pubTimestamp":1741034475,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时41分，Oric Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.23%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Celularity Inc C/Wts 16/07/2026 涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为215.94%、187.94%、164.66%，振幅较大的相关个股有Radiopharm Theranostics Limited、Entero Therapeutics Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为119.50%、70.53%、64.88%。Oric Pharmaceuticals, Inc.公司简介：ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。该公司的产品候选药物包括 ORIC-944、ORIC-114 和 ORIC-533。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304044115989a61a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304044115989a61a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2514330533","title":"Oric Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514330533","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514330533?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:55","pubTimestamp":1740689725,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时55分，Oric Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.06%。截至发稿，该股报7.88美元/股，成交量67.988万股，换手率0.96%，振幅8.43%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1954.27%、423.50%、197.98%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Oric Pharmaceuticals, Inc.公司简介：ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228045526abdfc290&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228045526abdfc290&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2514857703","title":"小摩：维持ORIC Pharmaceuticals(ORIC.US)评级，由增持调整至增持评级, 目标价由21.00美元调整至22.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514857703","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514857703?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:23","pubTimestamp":1740587009,"startTime":"0","endTime":"0","summary":"小摩：维持ORIC Pharmaceuticals(ORIC.US)评级，由增持调整至增持评级, 目标价由21.00美元调整至22.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/27002348413728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ORIC"],"gpt_icon":0},{"id":"2514048213","title":"Oric Pharmaceuticals, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514048213","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514048213?lang=zh_cn&edition=full","pubTime":"2025-02-26 02:52","pubTimestamp":1740509529,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日02时52分，Oric Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.03%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Organovo Holdings, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1922.45%、1151.59%、993.55%，振幅较大的相关个股有Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Silexion Therapeutics Corp，振幅分别为241.19%、112.90%、87.83%。Oric Pharmaceuticals, Inc.公司简介：ORIC Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226025209abdcbb66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226025209abdcbb66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2513621623","title":"HC Wainwright & Co.：重申ORIC Pharmaceuticals(ORIC.US)评级，由买入调整至买入评级, 目标价由21.00美元调整至21.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513621623","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513621623?lang=zh_cn&edition=full","pubTime":"2025-02-22 02:34","pubTimestamp":1740162872,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申ORIC Pharmaceuticals(ORIC.US)评级，由买入调整至买入评级, 目标价由21.00美元调整至21.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/22023448321214.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ORIC"],"gpt_icon":0},{"id":"2513929822","title":"Oric Pharmaceuticals, Inc.2024财年实现净利润-1.28亿美元，同比减少26.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513929822","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513929822?lang=zh_cn&edition=full","pubTime":"2025-02-22 00:00","pubTimestamp":1740153658,"startTime":"0","endTime":"0","summary":"2月22日，Oric Pharmaceuticals, Inc.公布财报，公告显示公司2024财年净利润为-1.28亿美元，同比减少26.73%；其中营业收入为0.00美元，每股基本收益为-1.83美元。从资产负债表来看，Oric Pharmaceuticals, Inc.总负债33.61百万美元，其中短期债务3.18百万美元，资产负债比为0.09，流动比率为0.11。机构评级：截至2025年2月22日，当前有11家机构对Oric Pharmaceuticals, Inc.目标价做出预测，其中目标均价为19.27美元，其中最低目标价为13.00美元，最高目标价为25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222000131abd7c349&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222000131abd7c349&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2513529662","title":"Oric Pharmaceuticals, Inc.盘中异动 股价大涨6.02%报7.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513529662","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513529662?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:32","pubTimestamp":1740148321,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时32分，Oric Pharmaceuticals, Inc.股票出现异动，股价大幅拉升6.02%。截至发稿，该股报7.92美元/股，成交量2.3812万股，换手率0.03%，振幅1.94%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Osr Holdings Inc C/Wts 09/02/2028 、Osr Holdings, Inc.、Nkgen Biotech, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、蓝鸟生物较为活跃，换手率分别为69.81%、62.73%、19.91%，振幅较大的相关个股有Osr Holdings, Inc.、Aspire Biopharma Holdings, Inc.、蓝鸟生物，振幅分别为17.39%、15.26%、11.05%。Oric Pharmaceuticals, Inc.公司简介：ORIC Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223201a24eb062&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223201a24eb062&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ORIC"],"gpt_icon":0},{"id":"2512165106","title":"Oric Pharmaceuticals, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165106","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512165106?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:42","pubTimestamp":1739889776,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时42分，Oric Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.02%。截至发稿，该股报8.78美元/股，成交量4.7338万股，换手率0.07%，振幅4.55%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Pulmatrix, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为303.34%、108.17%、86.77%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Conduit Pharmaceuticals Inc.、Pulmatrix, Inc.，振幅分别为34.04%、26.83%、23.16%。Oric Pharmaceuticals, Inc.公司简介：ORIC Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182242569889ff49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182242569889ff49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC","BK4139","BK4007","PULM"],"gpt_icon":0},{"id":"2511696798","title":"Oric Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.40%报8.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511696798","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511696798?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:31","pubTimestamp":1739543478,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时31分，Oric Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.40%。截至发稿，该股报8.72美元/股，成交量2.1421万股，换手率0.03%，振幅0.00%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Virpax Pharmaceuticals, Inc.、Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为987.87%、354.42%、318.30%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Theratechnologies Inc.、Virpax Pharmaceuticals, Inc.，振幅分别为20.20%、18.33%、15.20%。Oric Pharmaceuticals, Inc.公司简介：ORIC Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422311996231b3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422311996231b3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VRPX","ORIC","BK4007"],"gpt_icon":0},{"id":"2511272185","title":"Oric Pharmaceuticals, Inc.盘中异动 早盘大幅下跌5.40%报8.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511272185","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511272185?lang=zh_cn&edition=full","pubTime":"2025-02-14 00:27","pubTimestamp":1739464022,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日00时27分，Oric Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.40%。截至发稿，该股报8.94美元/股，成交量39.8483万股，换手率0.56%，振幅6.98%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。其相关个股中，Edesa Biotech, Inc.、Dominari Holdings Inc.、Pliant Therapeutics, Inc.涨幅较大，Edesa Biotech, Inc.、Tc Biopharm  Plc、Genprex, Inc.较为活跃，换手率分别为2750.37%、1177.21%、164.31%，振幅较大的相关个股有Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为95.15%、92.30%、42.61%。Oric Pharmaceuticals, Inc.公司简介：ORIC Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214002702abcdc8dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214002702abcdc8dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2510380591","title":"Oric Pharmaceuticals, Inc.盘中异动 早盘股价大跌8.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510380591","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510380591?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:35","pubTimestamp":1739284559,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时35分，Oric Pharmaceuticals, Inc.股票出现异动，股价急速下挫8.46%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.83%。其相关个股中，Dominari Holdings Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、Ocean Biomedical, Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.较为活跃，换手率分别为2088.90%、547.05%、182.55%，振幅较大的相关个股有In8Bio, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.，振幅分别为25.06%、22.23%、18.18%。Oric Pharmaceuticals, Inc.公司简介：ORIC Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112236019881bdda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112236019881bdda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC","OCEA","BK4139"],"gpt_icon":0},{"id":"2510864684","title":"Oric Pharmaceuticals, Inc.盘中异动 早盘股价大涨6.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510864684","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510864684?lang=zh_cn&edition=full","pubTime":"2025-02-11 00:04","pubTimestamp":1739203462,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日00时04分，Oric Pharmaceuticals, Inc.股票出现波动，股价大幅拉升6.04%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Biodexa Pharmaceuticals Plc涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为2748.80%、1545.77%、1053.83%，振幅较大的相关个股有Abpro Holdings Inc C/Wts 12/11/2029 、Ocean Biomedical, Inc.、Biodexa Pharmaceuticals Plc，振幅分别为87.80%、77.50%、73.46%。Oric Pharmaceuticals, Inc.公司简介：ORIC Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211000422a240b612&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211000422a240b612&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2509721935","title":"Oric Pharmaceuticals, Inc.盘中异动 急速跳水5.02%报11.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509721935","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509721935?lang=zh_cn&edition=full","pubTime":"2025-02-08 01:12","pubTimestamp":1738948335,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日01时12分，Oric Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.02%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.47%。其相关个股中，Conduit Pharmaceuticals Inc.、Nutriband Inc C/Wts 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为6171.13%、170.26%、110.39%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为130.43%、93.55%、53.38%。Oric Pharmaceuticals, Inc.公司简介：ORIC Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208011215abc64d78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208011215abc64d78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2509027202","title":"小摩：维持ORIC Pharmaceuticals(ORIC.US)评级，由增持调整至增持评级, 目标价由19.00美元调整至21.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509027202","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509027202?lang=zh_cn&edition=full","pubTime":"2025-02-07 02:05","pubTimestamp":1738865135,"startTime":"0","endTime":"0","summary":"小摩：维持ORIC Pharmaceuticals(ORIC.US)评级，由增持调整至增持评级, 目标价由19.00美元调整至21.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/07020548002774.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ORIC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.oricpharma.com","stockEarnings":[{"period":"1week","weight":-0.0403},{"period":"1month","weight":0.1705},{"period":"3month","weight":-0.1685},{"period":"6month","weight":0.0895},{"period":"1year","weight":-0.1257},{"period":"ytd","weight":0.3093}],"compareEarnings":[{"period":"1week","weight":-0.0021},{"period":"1month","weight":-0.0002},{"period":"3month","weight":0.016},{"period":"6month","weight":0.0761},{"period":"1year","weight":0.1551},{"period":"ytd","weight":0.0176}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ORIC Pharmaceuticals, Inc.在特拉华州注册，成立于2014年8月。该公司是临床阶段的生物制药公司，致力于通过克服癌症抵抗力来改善患者的生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.039993},{"month":2,"riseRate":0.5,"avgChangeRate":-0.058984},{"month":3,"riseRate":0.4,"avgChangeRate":-0.098966},{"month":4,"riseRate":0.2,"avgChangeRate":-0.164176},{"month":5,"riseRate":0.666667,"avgChangeRate":0.07899},{"month":6,"riseRate":0.666667,"avgChangeRate":0.141043},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.000511},{"month":8,"riseRate":0.666667,"avgChangeRate":0.090659},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.048915},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.0811},{"month":11,"riseRate":0.666667,"avgChangeRate":0.167402},{"month":12,"riseRate":0.5,"avgChangeRate":0.06155}],"exchange":"NASDAQ","name":"Oric Pharmaceuticals Inc.","nameEN":"Oric Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Oric Pharmaceuticals Inc.(ORIC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Oric Pharmaceuticals Inc.(ORIC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Oric Pharmaceuticals Inc.,ORIC,Oric Pharmaceuticals Inc.股票,Oric Pharmaceuticals Inc.股票老虎,Oric Pharmaceuticals Inc.股票老虎国际,Oric Pharmaceuticals Inc.行情,Oric Pharmaceuticals Inc.股票行情,Oric Pharmaceuticals Inc.股价,Oric Pharmaceuticals Inc.股市,Oric Pharmaceuticals Inc.股票价格,Oric Pharmaceuticals Inc.股票交易,Oric Pharmaceuticals Inc.股票购买,Oric Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Oric Pharmaceuticals Inc.(ORIC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Oric Pharmaceuticals Inc.(ORIC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}